BioNTech is a biotechnology company based in Germany, primarily known for its role in developing innovative immunotherapies and vaccines. The company gained widespread recognition for its collaboration with Pfizer in creating one of the first COVID-19 vaccines based on messenger RNA (mRNA) technology. Founded in 2008, BioNTech focuses on utilizing the body’s immune system to target and fight diseases, particularly cancer. Its research involves developing personalized therapies and combining various treatment modalities. The company has become a prominent player in the field of biotechnology and vaccine development, with a mission to transform the treatment of diseases through scientific innovation.
BioNTech is pivoting from COVID-19 vaccines to cancer therapies, leveraging mRNA technology. Despite a decline in quarterly profits, Q4 2024 earnings per share (EPS) of 1.08 euros exceeded expectations. The…